Cyprien Rivier, MD, MSc
InstructorCards
About
Research
Publications
2026
309 Proteomic Markers Associated With Risk of Normal Pressure Hydrocephalus: A Prospective Analysis From the UK Biobank
Renedo D, Rivier C, Koo A, Sujijantarat N, Amllay A, Fathima B, Haynes J, Hebert R, Falcone G, Matouk C. 309 Proteomic Markers Associated With Risk of Normal Pressure Hydrocephalus: A Prospective Analysis From the UK Biobank. Neurosurgery 2026, 72: 79-79. DOI: 10.1227/neu.0000000000003964_309.Peer-Reviewed Original ResearchLongitudinal Trajectories of Brain Health Risk Factors Measured by the Brain Care Score and Risk of Stroke, Dementia, and Depression
Kimball T, Tack R, Parodi L, Prapiadou S, Senff J, Tan B, Duperron M, Choksi D, Reinders E, Rivier C, Falcone G, Yechoor N, Singh S, Rosand J, Mayerhofer E, Anderson C. Longitudinal Trajectories of Brain Health Risk Factors Measured by the Brain Care Score and Risk of Stroke, Dementia, and Depression. Annals Of Neurology 2026 PMID: 41510843, DOI: 10.1002/ana.78145.Peer-Reviewed Original ResearchHealth risk factorsAssociated with reduced riskModifiable risk factorsRisk factor profileCare scoresRisk factorsGenetic riskFactor profileUK Biobank dataLongitudinal trajectoriesBrain health benefitsGeneral practitionersAssociated with lower incidenceRisk of strokeLinear mixed-effects modelsBiobank dataAge-related brain diseasesReal-world settingsMixed-effects modelsHealth benefitsLongitudinal changesSocial-emotional domainsCox modelLow riskMultivariate Cox model
2025
The Abbreviated Brain Care Score and Association With Incident Dementia, Stroke, and Late-Life Depression
Lazar R, Senff J, Bowen P, Jones C, Sheth K, Rivier C, Tack R, Reinders E, Sherman K, Anderson C, Rosand J, Singh S. The Abbreviated Brain Care Score and Association With Incident Dementia, Stroke, and Late-Life Depression. Neurology Open Access 2025, 1 DOI: 10.1212/wn9.0000000000000041.Peer-Reviewed Original ResearchU.S. public perceptions on whether risk of dementia and stroke can be modified through maintaining or changing lifestyle
Senff J, Shah-Ostrowski M, Tack R, Nunley C, Palys C, Ng S, Mallick A, Gutierrez-Martinez L, Duskin J, Kimball T, Prapiadou S, Marini S, Reinders E, Sherman K, Tinoble A, Brouwers H, Akhavan S, Towfighi A, Rivier C, Falcone G, Sheth K, Lazar R, Ibrahim S, Pikula A, Chemali Z, van Duijn C, Fricchione G, Tanzi R, Yechoor N, Anderson C, Greenaway V, Pouwels K, Rosand J, Singh S. U.S. public perceptions on whether risk of dementia and stroke can be modified through maintaining or changing lifestyle. BMC Public Health 2025, 25: 4191. PMID: 41316093, PMCID: PMC12664128, DOI: 10.1186/s12889-025-25077-x.Peer-Reviewed Original ResearchConceptsRisk of dementiaStroke riskChanging lifestylesLifestyle changesU.S. populationModifiable risk factorsEffective prevention strategiesDementia riskLevel of educationMultivariate logistic regression analysisCross-sectional cohortLogistic regression analysisHealthy lifestyleStroke casesEmployment statusMethodsA surveyBinary exposurePrevention strategiesDementiaLifestylePrimary outcomeBackgroundEpidemiological studiesRisk factorsParticipantsStrokeAdditive Effects of White Matter Hyperintensity and APOE ε4 Status on Risk of Incident Dementia in Two Large Longitudinal Cohorts
de Havenon A, Littig L, Clocchiatti‐Tuozzo S, Johnson I, Constantinescu S, Rivier C, Huo S, Kimberly W, Gomez‐Isla T, Kim Y, Stulberg E, Smith E, Rosand J, Falcone G, Sheth K, Brickman A. Additive Effects of White Matter Hyperintensity and APOE ε4 Status on Risk of Incident Dementia in Two Large Longitudinal Cohorts. Annals Of Neurology 2025, 99: 656-667. PMID: 41267647, PMCID: PMC12967297, DOI: 10.1002/ana.78103.Peer-Reviewed Original ResearchIncident all-cause dementiaDementia incidence ratesAll-cause dementiaApolipoprotein E e4 statusE4 statusHazard ratioRisk of incident all-cause dementiaRisk of incident dementiaWhite matter hyperintensitiesIncidence rateVascular risk managementDelay dementia onsetAdjusted hazard ratiosProspective cohort studyEffects of white matter hyperintensityApolipoprotein EAt-risk individualsCox proportional hazards modelsIncident dementiaDementia riskDementia onsetProportional hazards modelWhite matter hyperintensities burdensAtherosclerosis RiskARICSLAMF1 as a Risk Biomarker for Nontraumatic SAH: Evidence From a Multiomics Study
Renedo D, Koo A, Sujijantarat N, Clocchiatti-Tuozzo S, Huo S, Acosta J, Hebert R, Gunel M, Sansing L, Sheth K, Falcone G, Matouk C, Rivier C. SLAMF1 as a Risk Biomarker for Nontraumatic SAH: Evidence From a Multiomics Study. Stroke 2025, 57: 499-504. PMID: 41221640, PMCID: PMC12914581, DOI: 10.1161/strokeaha.125.052604.Peer-Reviewed Original ResearchMendelian randomizationSubarachnoid hemorrhage riskIncident SAH casesNontraumatic subarachnoid hemorrhageSubarachnoid hemorrhageUK BiobankSmoking statusClinical priorityPrevention strategiesCellular expression profilesCox proportional hazards analysisProportional hazards analysisRisk predictionCis-protein quantitative trait lociCD4 naive cellsSAH casesRisk biomarkersSubarachnoid hemorrhage pathophysiologyAdaptive immune responsesHuman hematopoietic progenitorsFollow-upQuantitative trait lociSingle-cell transcriptome analysisRiskCerebrovascular eventsDifferential results of genetic risk scoring for multiple sclerosis in European and African American populations
Rivier C, Xu L, Clocchiatti-Tuozzo S, Zhao H, Ohno-Machado L, Hafler D, Falcone G, Longbrake E. Differential results of genetic risk scoring for multiple sclerosis in European and African American populations. Multiple Sclerosis Journal 2025, 31: 1304-1313. PMID: 40991630, PMCID: PMC12633797, DOI: 10.1177/13524585251377607.Peer-Reviewed Original ResearchConceptsGenetic risk scoreInternational ClassificationSystematized Nomenclature of MedicineAfrican ancestryRisk scoreCross-sectional studyHigh-risk individualsMultiple sclerosisSystematized NomenclatureAfrican American populationAfrican ancestry groupMS prevalenceAncestry groupsMS riskNomenclature of MedicineAmerican populationParticipantsAfrican participantsAncestryEuropean populationsClinical trialsDifferentiation resultsScoresIndividualsPopulationCharacterizing Stroke Clots Using Single‐Cell Sequencing
Renedo D, Barak T, DeLong J, Acosta J, Sujijantarat N, Koo A, Rivier C, Clocchiatti-Tuozzo S, Huo S, Antonios J, Giles J, Falcone G, Sheth K, Hebert R, Gunel M, Sansing L, Navaratnam D, Matouk C. Characterizing Stroke Clots Using Single‐Cell Sequencing. Journal Of The American Heart Association 2025, 14: ejaha/2025/041738-t. PMID: 40878981, PMCID: PMC12553457, DOI: 10.1161/jaha.125.041738.Peer-Reviewed Original ResearchConceptsMulti-marker analysisGene expressionMulti-marker Analysis of GenoMic AnnotationCell type-specific gene expressionT cellsGenome-wide association studiesGene expression of cellsSingle-cell RNA sequencingPotential biomarkersTIMP1Genes associated with atherosclerosisHLA-DRB1*01Single-cell sequencingExpression of genesUpregulated expression of genesGene expression profilesCarotid atherosclerosisGenome annotationCD8 T cellsUpregulated expressionImmune cell compositionAssociation studiesNatural killer cellsImmune cell populationsLarge vessel occlusion strokePolygenic Resistance to Blood Pressure Treatment and Stroke Risk: Insights from the All of Us Research Program
Huo S, Rivier C, Clocchiatti‐Tuozzo S, Renedo D, Petersen N, de Havenon A, Meeker D, Zhao H, Ohno‐Machado L, Sheth K, Falcone G. Polygenic Resistance to Blood Pressure Treatment and Stroke Risk: Insights from the All of Us Research Program. Annals Of Neurology 2025, 99: 124-133. PMID: 40827941, DOI: 10.1002/ana.78009.Peer-Reviewed Original ResearchUs Research ProgramUncontrolled hypertensionSystolic BPGenetic riskSusceptibility to hypertensionRates of uncontrolled hypertensionPolygenic risk scoresAssociated with higher systolic BPOdds of uncontrolled hypertensionCox proportional hazards regressionUnited Kingdom BiobankGenetic association studiesHigh-risk individualsHigher systolic BPProportional hazards regressionBlood pressure treatmentIncident strokeStroke hazardBlood pressureHigher RatesSystolic blood pressureHypertensive adultsDiagnosed hypertensionBP medicationsHazards regressionAssociation of Polygenic Susceptibility to Hyperlipidemia With Cholesterol Control and Recurrent Stroke in Ischemic Stroke Survivors
Wu K, Huo S, Rivier C, Torres-Lopez V, Sharma R, de Havenon A, Worrall B, Sheth K, Falcone G. Association of Polygenic Susceptibility to Hyperlipidemia With Cholesterol Control and Recurrent Stroke in Ischemic Stroke Survivors. Neurology 2025, 105: e213966. PMID: 40825160, PMCID: PMC13014709, DOI: 10.1212/wnl.0000000000213966.Peer-Reviewed Original ResearchConceptsIschemic stroke survivorsStroke survivorsAssociated with riskSusceptible to hyperlipidemiaHigh riskUK BiobankResistant hyperlipidemiaCholesterol controlUncontrolled hyperlipidemiaSurvivors of ischemic strokeHigher risk of recurrent vascular eventsPolygenic risk scoresRisk factor controlRisk of recurrent vascular eventsAdverse genetic profileLow-density lipoprotein cholesterolRisk of acute coronary eventsGenetic association studiesRecurrent strokeClinical trajectoryGenetic risk variantsRisk of recurrent strokeAcute ischemic stroke survivorsPolygenic profilePrecision medicine tools
Academic Achievements & Community Involvement
News
News
- March 21, 2026Source: Prevention Health (with Cyprien Rivier, MD)
The Surprising Link Between Your Biological Age and Your Brain Health
- January 31, 2026
2025 OHER Awards for Yale Research Excellence
- June 24, 2025
Announcing the Center for Brain & Mind Health 2025 Pilot Grant Program Awardees
- November 20, 2024
Brain Bleeds: How Biological Sex Affects Severity and Outcomes
Get In Touch
Contacts
Mobile Phone Number